Authors:
Arthur Trognon
1
;
2
;
3
;
David Servais
3
;
4
;
Islem Habibi
2
;
3
;
Robert Picard
3
;
Thomas Lihoreau
5
;
3
;
6
;
Lionel Pazart
3
;
6
;
5
;
Sylvia Pelayo
7
;
3
;
8
;
Thierry Chevallier
3
;
5
;
8
;
Kathryn Ernecq
3
;
9
;
Anaïs Garin
3
;
10
;
Mathias Béjean
3
;
10
and
Denis Abraham
1
;
3
Affiliations:
1
Association Innov’Autonomie, Nancy, France
;
2
Clinicog, Nancy, France
;
3
Consortium DynSanté, n.d.
;
4
Forum des Living Labs en Santé et en Autonomie (LLSA), Paris, France
;
5
Tech4Health Network - FCRIN, France
;
6
Inserm CIC 1431, CHU Besançon, F-25000 Besançon, France
;
7
Université de Lille, Lille, France
;
8
University Hospitals of Nîmes, France
;
9
Frog Part of Capgemini, Paris, France
;
10
Paris Est Créteil University, IRG, F-94010, France
Keyword(s):
Maturity Evaluation, Technologies for Health, Medical Devices, Computational Psychology, Innovation.
Abstract:
Historically, evaluation methods for innovative projects have focused mainly on technological development aspects. However, recent research suggests that, in the context of consumption by the general public, the decision parameters for acceptance seem to be based more on characteristics extrinsic to technological maturity. In the present work, we present a model for the evaluation of innovative projects, the Concept Maturity Level Santé France model, inspired by the CML model developed by the National Aeronautics and Space Administration and specified in the context of MedTech project development, and placing co-design with the end-user and its ecosystem on the same level of importance as the regulatory and technological development aspects, and giving it a theoretical and fundamental basis.